[go: up one dir, main page]

WO2010012972A3 - Novel bacterial cells and uses thereof - Google Patents

Novel bacterial cells and uses thereof Download PDF

Info

Publication number
WO2010012972A3
WO2010012972A3 PCT/GB2009/001433 GB2009001433W WO2010012972A3 WO 2010012972 A3 WO2010012972 A3 WO 2010012972A3 GB 2009001433 W GB2009001433 W GB 2009001433W WO 2010012972 A3 WO2010012972 A3 WO 2010012972A3
Authority
WO
WIPO (PCT)
Prior art keywords
gene
cell
orf18
homologue
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2009/001433
Other languages
French (fr)
Other versions
WO2010012972A2 (en
Inventor
Michael Gasson
Claire Shearman
Regis Stentz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Plant Bioscience Ltd
Original Assignee
Plant Bioscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plant Bioscience Ltd filed Critical Plant Bioscience Ltd
Publication of WO2010012972A2 publication Critical patent/WO2010012972A2/en
Publication of WO2010012972A3 publication Critical patent/WO2010012972A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/06—Treating cheese curd after whey separation; Products obtained thereby
    • A23C19/061—Addition of, or treatment with, microorganisms
    • A23C19/062—Addition of, or treatment with, microorganisms using only lactic acid bacteria, e.g. pediococcus, leconostoc or bifidus sp., or propionic acid bacteria; Treatment with non-specified acidifying bacterial cultures
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/20—Synthetic spices, flavouring agents or condiments
    • A23L27/24—Synthetic spices, flavouring agents or condiments prepared by fermentation
    • A23L27/25—Dairy flavours
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8103—Exopeptidase (E.C. 3.4.11-19) inhibitors
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The present invention provides a bacterial host cell having improved cell permeability properties, the cell comprising an Orf18 gene or species homologue thereof, or a fragment or variant of the same encoding a polypeptide having the activity of the Orf18 gene product or species homologue thereof, wherein the gene, homologue, fragment or variant is under the control of an heterologous promoter (inducible or constitutively active) which permits sufficient expression of the gene, homologue, fragment or variant to increase the permeability of the cell wall. "Orf18 and the "orf18 gene" are also known as "CsiA" and the "csiA gene" respectively. In one embodiment, the host cell is a Lactococcus lactis cell in which a chromosomally-integrated Orf18 gene naturally present in the cell is inactivated. The invention further provides the use of such host cells in the production of polypeptides. In addition, the invention provides pharmaceutical compositions of the host cells and the use thereof for administering a bioactive agent to the human or animal body (for example, to the Gl tract).
PCT/GB2009/001433 2008-06-05 2009-06-05 Novel bacterial cells and uses thereof Ceased WO2010012972A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12910908P 2008-06-05 2008-06-05
US61/129,109 2008-06-05

Publications (2)

Publication Number Publication Date
WO2010012972A2 WO2010012972A2 (en) 2010-02-04
WO2010012972A3 true WO2010012972A3 (en) 2010-04-01

Family

ID=41467002

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2009/001433 Ceased WO2010012972A2 (en) 2008-06-05 2009-06-05 Novel bacterial cells and uses thereof

Country Status (1)

Country Link
WO (1) WO2010012972A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2386641A1 (en) 2010-05-11 2011-11-16 Université Catholique De Louvain Method for extracellular production of recombinant biomolecules in a microorganism
CN102174487B (en) * 2010-12-20 2012-11-07 江苏省农业科学院 Listeria phage endolysin and preparation method as well as application thereof
DK3369742T3 (en) * 2011-10-05 2020-10-19 Univ Rockefeller DIMBER BACTERIO PHAGLICIANS
CN106148455B (en) * 2015-03-25 2020-10-02 普莱柯生物工程股份有限公司 Inducer and application thereof
EP3692149B1 (en) * 2017-10-06 2023-01-04 Micreos Human Health B.V. Treatment of a condition associated with infection with an oncogenic bacterium
CN107670023B (en) * 2017-10-10 2021-10-22 中国科学院武汉病毒研究所 A new application of V12CBD protein and its encoding gene
CN114214436B (en) * 2021-11-17 2024-06-11 中国水产科学研究院南海水产研究所 Vibrio harveyi 345 gene knockout strain and application thereof

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE UniProt [online] 6 March 2007 (2007-03-06), "SubName: Full=Putative uncharacterized protein;", XP002564517, retrieved from EBI accession no. UNIPROT:A2RL11 Database accession no. A2RL11 *
MILLS SUSAN ET AL: "Insertional inactivation of determinants for Mg2+ and Co2+ transport as a tool for screening recombinant Lactococcus species clones.", August 2005, APPLIED AND ENVIRONMENTAL MICROBIOLOGY AUG 2005, VOL. 71, NR. 8, PAGE(S) 4897 - 4901, ISSN: 0099-2240, XP002564534 *
RUYTER DE P G G A ET AL: "FOOD-GRADE CONTROLLED LYSIS OF LACTOCOCCUS LACTIS FOR ACCELERATED CHEESE RIPENING", NATURE BIOTECHNOLOGY, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 15, no. 10, 1 October 1997 (1997-10-01), pages 976 - 979, XP008042228, ISSN: 1087-0156 *
STENTZ REGIS ET AL: "CsiA is a bacterial cell wall synthesis inhibitor contributing to DNA translocation through the cell envelope", MOLECULAR MICROBIOLOGY, vol. 72, no. 3, May 2009 (2009-05-01), pages 779 - 794, XP002564516 *
WEGMANN U ET AL: "Complete genome sequence of the prototype lactic acid bacterium Lactococcus lactis subsp cremoris MG1363", 1 April 2007, JOURNAL OF BACTERIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, PAGE(S) 3256 - 3270, ISSN: 0021-9193, XP002465567 *

Also Published As

Publication number Publication date
WO2010012972A2 (en) 2010-02-04

Similar Documents

Publication Publication Date Title
Lahiri et al. Bacteriocin: A natural approach for food safety and food security
WO2010012972A3 (en) Novel bacterial cells and uses thereof
Zhang et al. Expression of plectasin in Pichia pastoris and its characterization as a new antimicrobial peptide against Staphyloccocus and Streptococcus
CN102199196B (en) Gene engineering antibacterial peptide and preparation method and application thereof
US8383102B2 (en) Fusion of peptidoglycan hydrolase enzymes to a protein transduction domain allows eradication of both extracellular and intracellular gram positive pathogens
ES2864373T3 (en) Methods for healing
MX362028B (en) Extended recombinant polypeptides and compositions comprising same.
AU2015279705B2 (en) Acinetobacter lysins
GB201018518D0 (en) Novel endolysin
AU2010288559A8 (en) New endolysin OBPgpLYS
JP2018502600A5 (en)
MX2011013453A (en) Antimicrobial agents.
NZ587105A (en) Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
IN2012DN03368A (en)
EP2661495A1 (en) Fusion of peptidoglycan hydrolase enzymes to a protein transduction domain allows eradication of both extracellular and intracellular gram positive pathogens
NZ597306A (en) Mesenchymal stem cell differentiation
Lin et al. Characterization and bioactivity of hepcidin-2 in zebrafish: Dependence of antibacterial activity upon disulfide bridges
WO2020186207A8 (en) Non-viral dna vectors and uses thereof for expressing fviii therapeutics
WO2017084985A1 (en) Bacteriocin composition and method
WO2009046464A8 (en) Articular cartilage gene therapy with recombinant vector encoding bmp-7
CN116685204A (en) Modulation of Antimicrobial Peptide Half-Life
Kojic et al. Cloning and expression of a novel lactococcal aggregation factor from Lactococcus lactis subsp. lactis BGKP1
Huynh et al. Efficient production of recombinant protegrin-1 from Pichia pastoris, and its antimicrobial and in vitro cell migration activity
US8569449B2 (en) Synthetic peptides and peptide mimetics
Niu et al. The molecular design of a recombinant antimicrobial peptide CP and its in vitro activity

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09784598

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09784598

Country of ref document: EP

Kind code of ref document: A2